Banner Corporation (NASDAQ GSM: BANR) has announced the addition of Mark Borrecco as the Chief Banking Officer. Borrecco is now responsible for overseeing the Bank’s production lines of business, ...

Wells Fargo & Company (NYSE: WFC) has issued a statement regarding a formal agreement between Wells Fargo Bank, N.A. and the Office of the Comptroller of the Currency (OCC) related to the bank’s ...

Additionally, in accordance with the terms of Redwood's 10.00% Series A Fixed-Rate Reset Cumulative Redeemable Preferred Stock ("Series A"), the board has authorized the declaration of a Series A ...

Cassava Sciences, Inc. (NASDAQ: SAVA) has appointed Richard (Rick) Barry as its CEO, separating the positions of CEO and Chairman by appointing Claude Nicaise, M.D. as Chairman. Dr. Nicaise has held ...

The proposed changes detailed in the definitive special proxy statement include a transition of MSC Income Fund's investment strategy and portfolio to focus solely on its private loan investment ...

Overall, there is mixed market sentiment towards Vale because of an analyst consensus of strong upside potential, a buy rating, a very low short interest, and a very small number of institutional ...

Today the company's shares have moved 23.6% to a price of $25.99. For the full picture, make sure to review Lovesac's 10-Q report.

Philip Morris International Inc. has announced an increase in its regular quarterly dividend by 3.8% to an annualized rate of $5.40 per share. The new quarterly dividend of $1.35 per share, up from $1 ...

Agilent Technologies sank -2.1% today, compared to the S&P 500's day change of 1.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an ...

Victory Capital Holdings, Inc. has reported its total client assets for August 2024, revealing key changes from the previous period. As of August 31, 2024, the company's total assets under management ...

Aura Biosciences, Inc. (NASDAQ: AURA) has reported positive phase 2 end of study results for their first-line treatment of early-stage choroidal melanoma (CM) using Bel-sar (AU-011). The results were ...